OTHARIS

ADC Therapeutics S.A.

ADCT · NYSE · CH

USD 1.65 +7.52% today

As of Nov 02, 2026 17:39 UTC — not a live feed

52-week range
USD 0.78 lowat 21% of its rangehigh 4.98
Market Cap
0.2B USD
Sector
Healthcare
Industry
Biotechnology

ADC Therapeutics S.A. (ADCT) is a Biotechnology company in the Healthcare sector, listed on NYSE. At USD 1.65 it trades at 21% of its 52-week range (USD 0.78 – 4.98).

Otharis Plus · ProAnalysed Nov 02, 2026 from its filings

Is ADC Therapeutics S.A. worth more than its price — and is its growth accelerating?

Two complete methods, run on ADCT's own numbers: Benjamin Graham's value test and the Otharis Growth Score. Every number is real and computed — never estimated.

Value Investing · Benjamin Graham7 criteria · value vs price · margin of safety
  • Size
  • Financial strength
  • Earnings stability
  • Dividend record
  • Earnings growth
  • Moderate P/E
  • Moderate price-to-book
Growth Investing · Otharis Growth Score7 criteria · speed · acceleration · margins
  • Revenue growth
  • Acceleration
  • EPS growth
  • Latest quarter
  • Margin expansion
  • Growth efficiency
  • Price momentum

The verdict, the values and every number behind them are inside Otharis.

✨

Otharis Research Free

A real, deterministic 22-section research report for ADCT - every line tagged FACT, MODEL OUTPUT, ASSUMPTION, ESTIMATE or RULE-BASED INTERPRETATION. 2 reports a day with a free account.

Unlock ADCT’s full analysis →

Start with a free account · Value & Growth analysis included in Otharis Plus and Pro